[HTML][HTML] Myelitis features and outcomes in CNS demyelinating disorders: comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD

G Fadda, EP Flanagan, L Cacciaguerra… - Frontiers in …, 2022 - frontiersin.org
Inflammatory myelopathies can manifest with a combination of motor, sensory and
autonomic dysfunction of variable severity. Depending on the underlying etiology, the …

Neuromyelitis optica spectrum disorders

F Costello - CONTINUUM: Lifelong Learning in Neurology, 2022 - journals.lww.com
PURPOSE OF REVIEW This article reviews the cardinal clinical features, distinct
immunopathology, current diagnostic criteria, relapse-related risk factors, emerging …

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD)–revised recommendations of the Neuromyelitis Optica Study Group …

T Kümpfel, K Giglhuber, O Aktas, I Ayzenberg… - Journal of …, 2024 - Springer
This manuscript presents practical recommendations for managing acute attacks and
implementing preventive immunotherapies for neuromyelitis optica spectrum disorders …

Comparison of clinical outcomes of transverse myelitis among adults with myelin oligodendrocyte glycoprotein antibody vs aquaporin-4 antibody disease

R Mariano, S Messina, K Kumar, W Kuker… - JAMA Network …, 2019 - jamanetwork.com
Importance Recognizing the differences between transverse myelitis (TM) associated with
myelin oligodendrocyte glycoprotein (MOG) antibody (Ab) disease vs aquaporin-4 (AQP4) …

Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects

SA Brod - Multiple sclerosis and related disorders, 2020 - Elsevier
Importance Neuromyelitis optica (NMO-including NMO spectrum disorders [NMOSD]) is a
devastating disease. Eighty-three percent of patients with transverse myelitic (TM) attacks …

[HTML][HTML] Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort

E Carnero Contentti, V Daccach Marques… - Journal of …, 2020 - Springer
Background We aimed to assess the clinical, paraclinical, imaging and prognostic features
of patients with late-onset neuromyelitis optica spectrum disorder (LO-NMOSD;≥ 50 years …

Anti-MOG associated disorder–Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD–A single-center experience

T Rempe, B Tarhan, E Rodriguez… - Multiple sclerosis and …, 2021 - Elsevier
Background The discovery of two immunoglobulin G (IgG) antibodies against aquaporin 4
(anti-AQP4) and myelin oligodendrocyte glycoprotein (anti-MOG) has led to the distinction of …

NMOSD acute attack: Understanding, treatment and innovative treatment prospect

X Ma, AG Kermode, X Hu, W Qiu - Journal of neuroimmunology, 2020 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is a group of severe inflammatory
demyelinating disorders of the central nervous system that involves the optic nerve and …

Risk of relapse in patients with neuromyelitis optica spectrum disorder: recognition and preventive strategy

X Ma, AG Kermode, X Hu, W Qiu - Multiple Sclerosis and Related Disorders, 2020 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune inflammatory
disorder of the central nervous system (CNS) that is mainly associated with serum …

A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course

JM Solomon, F Paul, C Chien, J Oh… - Therapeutic …, 2021 - journals.sagepub.com
Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, inflammatory disease of the
central nervous system marked by relapses often associated with poor recovery and long …